MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12029-025-01290-0

Медицинская библиотека · Journal of gastrointestinal cancer · 2025

Effects of Sarcopenia on Patient Outcomes in Gastrointestinal Cancer: An Umbrella Review of Published Meta-Analyses.

Ramírez-Giraldo Camilo, Venegas-Sanabria Luis Carlos, Pesce Antonio, González-Muñoz Alejandro, Van-Londoño Isabella, Isaza-Restrepo Andrés

СтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

Gastrointestinal tumors represent a significant proportion of malignant neoplasms worldwide. Sarcopenia has emerged as a clinically relevant prognostic factor. Defined as the progressive and generalized loss of skeletal muscle mass and function, sarcopenia has been associated with adverse outcomes in oncological patients.

METHODS

We conducted an umbrella review of accumulated evidence to evaluate sarcopenia as a risk factor for major complications (Clavien-Dindo ≥ 3) and overall survival in patients with gastrointestinal cancer. A systematic search of PubMed and Embase was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

RESULTS

Sixty-three studies were included. Among the 29 studies that reported major complications, 19 studies (65.51%) identified sarcopenia as a risk factor, while the others did not find a statistically significant difference in the overall effect. Strong evidence (Class II) indicated that sarcopenia is associated with an increased risk of major complications (eOR = 1.56, 95% CI 1.40-1.75). Conversely, 56 of the included studies reported overall survival as the primary outcome of interest, with 52 (92.85%) identifying sarcopenia as a risk factor for reduced survival. Strong evidence (Class II) supports that sarcopenia is linked to reduced survival (eOR = 1.79, 95% CI 1.71-1.88).

CONCLUSION

This umbrella review of accumulated evidence demonstrates that sarcopenia is a highly suggestive risk factor for major postoperative complications and reduced overall survival in patients with gastrointestinal tumors. Consequently, the identification of sarcopenia in this patient population should prompt the implementation of preventive and therapeutic interventions aimed at improving clinical outcomes.

Для цитирования: Ramírez-Giraldo Camilo, Venegas-Sanabria Luis Carlos, Pesce Antonio, González-Muñoz Alejandro, Van-Londoño Isabella, Isaza-Restrepo Andrés. Effects of Sarcopenia on Patient Outcomes in Gastrointestinal Cancer: An Umbrella Review of Published Meta-Analyses.. Journal of gastrointestinal cancer. 2025. DOI: 10.1007/s12029-025-01290-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.